Healthcare and Life Science
Cambridge Innovation Capital commits £100m to back University of Cambridge spinouts
New Entrepreneur in Residence programme matches serial entrepreneurs with academics to develop world-leading ideas and IP. ...
UK perspective: Harnessing the power of global collaboration in Precision Oncology
Disclaimer:The views expressed in this article reflect the professional perspective and experience of Excellence First Enterprise Consultancy Ltd (EFEC). This content is intended for informational purposes only and does not constitute commercial endorsement, medical advice, or solicit...
Construction partner appointed for new Cambridge Children’s Hospital
The Cambridge Children’s Hospital project has appointed Bouygues UK as its construction partner for a groundbreaking new hospital that will redefine how we care for children and young people. ...
CPFT psychiatrist publishes book to guide person-centred care
Dr Robert Dudas, consultant old age psychiatrist at Cambridgeshire and Peterborough NHS Foundation Trust (CPFT), has edited and published a new book to support best practice for mental health care and recovery. ...
Insights from the UK Life Sciences Start-up Report 2025: Building bridges with China for mutual growth
Disclaimer: This article is for informational purposes only and reflects the author’s independent observations on the UK life sciences sector and international collaboration opportunities. It does not constitute investment advice. ...
First non-hormonal menopause treatment approved for use in the UK by the MHRA, with early-stage development at Stevenage Bioscience Catalyst
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved elinzanetant (branded as Lynkuet™) for the treatment of moderate to severe hot flushes and night sweats associated with menopause. These symptoms, also known as vasomotor symptoms, affect a significant pr...
Strategic momentum: Building UK–China bridges in life sciences through Wuhan
Disclaimer: This article reflects EFEC’s views and insights based on information available as of August 2025. While believed to be accurate, some data are estimates or projections and may change over time. It is provided for general information only and does not constitute professional,...
Study prompts global call on pituitary tumour research
Brain surgeons and researchers from Cambridge and London are calling on colleagues worldwide to adopt the first ever consistent way of recording outcomes following pituitary gland tumour removal. ...
China’s First National Medical Insurance Standard: £145bn Opportunity for UK Life Sciences
Insight from Excellence First Enterprise Consultancy (EFEC) Disclaimer: This article is for general information only and does not constitute professional, financial, or legal advice. Market projections are based on current data and subject to change. ...
Revenue growth continues - H1 and Q2 2025 results
Pascal Soriot, Chief Executive Officer, AstraZeneca, commenting on the results said:“Our strong momentum in revenue growth continued through the first half of the year and the delivery from our broad and diverse pipeline has been excellent, with 12 positive key Phase III trial readout...